Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients - a prospective, comparative, non-randomised study

By Fiets W.E.   van Helvoirt R.P.   Nortier J.W.R.   van der Tweel I.   Struikmans H.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1081-1088

Elsevier

Access to resources Recommend Favorite

Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer

By Mariani L.   Salvadori B.   Marubini E.   Conti A.R.   Rovini D.   Cusumano F.   Rosolin T.   Andreola S.   Zucali R.   Rilke F.   Veronesi U.  

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1156-1162

Elsevier

Access to resources Recommend Favorite

Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study

By Colozza M.   Bisagni G.   Mosconi A.M.   Gori S.   Boni C.   Sabbatini R.   Frassoldati A.   Passalacqua R.   Bian A.R.   Rodino C.   Rondini E.   Algeri R.   Di Sarra S.   De Angelis V.   Cocconi G.   Tonato M.   on behalf of the Italian Oncology Group for Clinical Research GOIRC  

European Journal of Cancer, Vol. 38, Iss. 17, 2002-11 ,pp. : 2279-2288

Elsevier

Access to resources Recommend Favorite

Postoperative Adjuvant Randomised Trial Comparing Chemoendocrine Therapy, Chemotherapy and Immunotherapy for Patients with Stage II Breast Cancer: 5-year Results from The Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan

By Morimoto T.   Ogawa M.   Orita K.   Sugimachi K.   Toge T.   Dohi K.   Nomura Y.   Monden Y.   Ogawa N.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 235-242

Elsevier

Access to resources Recommend Favorite

Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer

By Namer M.   Soler-Michel P.   Turpin F.   Chinet-Charrot P.   de Gislain C.   Pouillart P.   Delozier T.   Luporsi E.   Etienne P.L.   Schraub S.   Eymard J.C.   Serin D.   Ganem G.   Calais G.   Maillart P.   Colin P.   Trillet-Lenoir V.   Prevost G.   Tigaud D.   Clavere P.   Marti P.   Romieu G.   Wendling J.L.  

European Journal of Cancer, Vol. 37, Iss. 9, 2001-06 ,pp. : 1132-1140

Elsevier

Access to resources Recommend Favorite